Matches in SemOpenAlex for { <https://semopenalex.org/work/W4385327401> ?p ?o ?g. }
- W4385327401 endingPage "2947" @default.
- W4385327401 startingPage "2929" @default.
- W4385327401 abstract "Pancreatic ductal adenocarcinoma (PDAC) is not sensitive to immune checkpoint blockade therapy, and negative feedback of tumor immune evasion might be partly responsible. We isolated CD8+ T cells and cultured them in vitro. Proteomics analysis was performed to compare changes in Panc02 cell lines cultured with conditioned medium, and leucine-rich repeat kinase 2 (LRRK2) was identified as a differential gene. LRRK2 expression was related to CD8+ T cell spatial distribution in PDAC clinical samples and upregulated by CD8+ T cells via interferon gamma (IFN-γ) simulation in vitro. Knockdown or pharmacological inhibition of LRRK2 activated an anti-pancreatic cancer immune response in mice, which meant that LRRK2 acted as an immunosuppressive gene. Mechanistically, LRRK2 phosphorylated PD-L1 at T210 to inhibit its ubiquitination-mediated proteasomal degradation. LRRK2 inhibition attenuated PD-1/PD-L1 blockade-mediated, T cell-induced upregulation of LRRK2/PD-L1, thus sensitizing the mice to anti-PD-L1 therapy. In addition, adenosylcobalamin, the activated form of vitamin B12, which was found to be a broad-spectrum inhibitor of LRRK2, could inhibit LRRK2 in vivo and sensitize PDAC to immunotherapy as well, which potentially endows LRRK2 inhibition with clinical translational value. Therefore, PD-L1 blockade combined with LRRK2 inhibition could be a novel therapy strategy for PDAC." @default.
- W4385327401 created "2023-07-28" @default.
- W4385327401 creator A5004829334 @default.
- W4385327401 creator A5013539817 @default.
- W4385327401 creator A5013855342 @default.
- W4385327401 creator A5014883198 @default.
- W4385327401 creator A5018957500 @default.
- W4385327401 creator A5020463692 @default.
- W4385327401 creator A5026242985 @default.
- W4385327401 creator A5028097829 @default.
- W4385327401 creator A5034676224 @default.
- W4385327401 creator A5042678330 @default.
- W4385327401 creator A5044277116 @default.
- W4385327401 creator A5052087233 @default.
- W4385327401 creator A5056443773 @default.
- W4385327401 creator A5057978323 @default.
- W4385327401 creator A5059933016 @default.
- W4385327401 creator A5062179244 @default.
- W4385327401 creator A5065128035 @default.
- W4385327401 creator A5071694248 @default.
- W4385327401 creator A5080777187 @default.
- W4385327401 creator A5083304846 @default.
- W4385327401 creator A5084144069 @default.
- W4385327401 creator A5085258745 @default.
- W4385327401 date "2023-10-01" @default.
- W4385327401 modified "2023-10-11" @default.
- W4385327401 title "Targeting leucine-rich repeat serine/threonine-protein kinase 2 sensitizes pancreatic ductal adenocarcinoma to anti-PD-L1 immunotherapy" @default.
- W4385327401 cites W1964914409 @default.
- W4385327401 cites W1984817636 @default.
- W4385327401 cites W1987160330 @default.
- W4385327401 cites W1992365739 @default.
- W4385327401 cites W2016983859 @default.
- W4385327401 cites W202433591 @default.
- W4385327401 cites W2031674559 @default.
- W4385327401 cites W2049619163 @default.
- W4385327401 cites W2052313621 @default.
- W4385327401 cites W2057893793 @default.
- W4385327401 cites W2063127941 @default.
- W4385327401 cites W2107277218 @default.
- W4385327401 cites W2121516058 @default.
- W4385327401 cites W2136731993 @default.
- W4385327401 cites W2148716917 @default.
- W4385327401 cites W2163856919 @default.
- W4385327401 cites W2165790578 @default.
- W4385327401 cites W2192080449 @default.
- W4385327401 cites W2293645537 @default.
- W4385327401 cites W2414977199 @default.
- W4385327401 cites W2435243879 @default.
- W4385327401 cites W2516619560 @default.
- W4385327401 cites W2538063110 @default.
- W4385327401 cites W2544360569 @default.
- W4385327401 cites W2558219863 @default.
- W4385327401 cites W2564351475 @default.
- W4385327401 cites W2613155082 @default.
- W4385327401 cites W2753065806 @default.
- W4385327401 cites W2787095966 @default.
- W4385327401 cites W2806366257 @default.
- W4385327401 cites W2898336689 @default.
- W4385327401 cites W2899882025 @default.
- W4385327401 cites W2922275293 @default.
- W4385327401 cites W2947469817 @default.
- W4385327401 cites W2959096163 @default.
- W4385327401 cites W2968188498 @default.
- W4385327401 cites W3042568371 @default.
- W4385327401 cites W3049211611 @default.
- W4385327401 cites W3093442491 @default.
- W4385327401 cites W3128646645 @default.
- W4385327401 cites W3153075376 @default.
- W4385327401 cites W3183514487 @default.
- W4385327401 cites W3198370512 @default.
- W4385327401 cites W4206841660 @default.
- W4385327401 cites W4210541679 @default.
- W4385327401 cites W4211253487 @default.
- W4385327401 cites W4220695835 @default.
- W4385327401 cites W4220914612 @default.
- W4385327401 cites W4221001991 @default.
- W4385327401 cites W4224982677 @default.
- W4385327401 cites W4281253153 @default.
- W4385327401 cites W4282914791 @default.
- W4385327401 doi "https://doi.org/10.1016/j.ymthe.2023.07.021" @default.
- W4385327401 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37515321" @default.
- W4385327401 hasPublicationYear "2023" @default.
- W4385327401 type Work @default.
- W4385327401 citedByCount "0" @default.
- W4385327401 crossrefType "journal-article" @default.
- W4385327401 hasAuthorship W4385327401A5004829334 @default.
- W4385327401 hasAuthorship W4385327401A5013539817 @default.
- W4385327401 hasAuthorship W4385327401A5013855342 @default.
- W4385327401 hasAuthorship W4385327401A5014883198 @default.
- W4385327401 hasAuthorship W4385327401A5018957500 @default.
- W4385327401 hasAuthorship W4385327401A5020463692 @default.
- W4385327401 hasAuthorship W4385327401A5026242985 @default.
- W4385327401 hasAuthorship W4385327401A5028097829 @default.
- W4385327401 hasAuthorship W4385327401A5034676224 @default.
- W4385327401 hasAuthorship W4385327401A5042678330 @default.
- W4385327401 hasAuthorship W4385327401A5044277116 @default.
- W4385327401 hasAuthorship W4385327401A5052087233 @default.
- W4385327401 hasAuthorship W4385327401A5056443773 @default.